• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

睡眠片段化和睡眠-觉醒周期失调与阿尔茨海默病所致轻度认知障碍患者的脑tau蛋白负荷相关:病例系列研究

Sleep Fragmentation and Sleep-Wake Cycle Dysregulation Are Associated with Cerebral Tau Burden in Patients with Mild Cognitive Impairment due to Alzheimer's Disease: A Case Series.

作者信息

Fernandes Mariana, Chiaravalloti Agostino, Cassetta Emanuele, Placidi Fabio, Mercuri Nicola Biagio, Liguori Claudio

机构信息

Department of Systems Medicine, University of Rome "Tor Vergata", Rome, Italy.

Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Rome, Italy.

出版信息

J Alzheimers Dis Rep. 2024 Sep 18;8(1):1275-1283. doi: 10.3233/ADR-230187. eCollection 2024.

DOI:10.3233/ADR-230187
PMID:39434815
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11491934/
Abstract

BACKGROUND

Although disturbed sleep is frequent in patients with mild cognitive impairment (MCI) and dementia due to Alzheimer's disease (AD), the association between sleep and tau pathology is unclear.

OBJECTIVE

This case series focused on measuring the sleep-wake rhythm over 7 days through actigraphy in patients diagnosed with MCI due to AD. Further, the association between sleep-wake cycle and tau deposition measured through positron emission tomography (PET) was explored.

METHODS

This case series included 6 MCI due to AD patients (2 women and 4 men, mean age 73.17±5.53 years), who completed neuropsychological testing, 7-day actigraphy, and tau PET imaging with radiolabeled compounds aimed to estimate the density and distribution of aggregated tau neurofibrillary tangles in the brain.

RESULTS

The case series indicated that patients with MCI due to AD who exhibited greater tau deposition in the frontal, parietal, and limbic regions, as well as in the precuneus and olfactory regions, also showed increased sleep fragmentation, as measured through actigraphy.

CONCLUSION

The findings from this case series suggest a potential link between tau deposition in key brain regions associated with AD and both sleep fragmentation and sleep-wake cycle dysregulation in a small sample of patients with MCI due to AD. These preliminary results warrant further investigation in larger, more comprehensive studies to confirm and expand upon these findings.

摘要

背景

尽管睡眠障碍在轻度认知障碍(MCI)患者和阿尔茨海默病(AD)所致痴呆患者中很常见,但睡眠与tau蛋白病理之间的关联尚不清楚。

目的

本病例系列重点通过活动记录仪测量诊断为AD所致MCI患者7天的睡眠-觉醒节律。此外,还探讨了通过正电子发射断层扫描(PET)测量的睡眠-觉醒周期与tau蛋白沉积之间的关联。

方法

本病例系列包括6例AD所致MCI患者(2名女性和4名男性,平均年龄73.17±5.53岁),他们完成了神经心理学测试、7天的活动记录仪监测以及使用放射性标记化合物的tau蛋白PET成像,旨在估计大脑中聚集的tau蛋白神经原纤维缠结的密度和分布。

结果

该病例系列表明,AD所致MCI患者在额叶、顶叶、边缘叶区域以及楔前叶和嗅觉区域tau蛋白沉积较多,通过活动记录仪测量,这些患者的睡眠片段化也增加。

结论

该病例系列的研究结果表明,在一小部分AD所致MCI患者中,与AD相关的关键脑区的tau蛋白沉积与睡眠片段化和睡眠-觉醒周期失调之间可能存在联系。这些初步结果值得在更大、更全面的研究中进一步调查,以证实和扩展这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a310/11491934/8d18f1457215/adr-8-adr230187-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a310/11491934/a27fb3f2926c/adr-8-adr230187-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a310/11491934/8d18f1457215/adr-8-adr230187-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a310/11491934/a27fb3f2926c/adr-8-adr230187-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a310/11491934/8d18f1457215/adr-8-adr230187-g002.jpg

相似文献

1
Sleep Fragmentation and Sleep-Wake Cycle Dysregulation Are Associated with Cerebral Tau Burden in Patients with Mild Cognitive Impairment due to Alzheimer's Disease: A Case Series.睡眠片段化和睡眠-觉醒周期失调与阿尔茨海默病所致轻度认知障碍患者的脑tau蛋白负荷相关:病例系列研究
J Alzheimers Dis Rep. 2024 Sep 18;8(1):1275-1283. doi: 10.3233/ADR-230187. eCollection 2024.
2
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation.阿尔茨海默病的睡眠-觉醒周期与 Tau 病理学和食欲素失调有关。
J Alzheimers Dis. 2020;74(2):501-508. doi: 10.3233/JAD-191124.
3
Quantitative F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients.认知正常的老年人、轻度认知障碍患者及阿尔茨海默病患者的定量F-AV1451脑tau蛋白PET成像
Front Neurol. 2019 May 15;10:486. doi: 10.3389/fneur.2019.00486. eCollection 2019.
4
Sleep Dysregulation Is Associated with F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.睡眠失调与阿尔茨海默病中的氟代脱氧葡萄糖正电子发射断层扫描(F-FDG PET)及脑脊液生物标志物相关。
J Alzheimers Dis Rep. 2023 Aug 10;7(1):845-854. doi: 10.3233/ADR-220111. eCollection 2023.
5
Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.采用多模态范式,利用THK5317正电子发射断层扫描(PET)对阿尔茨海默病体内的tau病理进行成像。
Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1686-99. doi: 10.1007/s00259-016-3363-z. Epub 2016 Mar 21.
6
Inferior and medial temporal tau and cortical amyloid are associated with daily functional impairment in Alzheimer's disease.内侧颞叶和皮质淀粉样蛋白与阿尔茨海默病患者的日常功能损害有关。
Alzheimers Res Ther. 2019 Jan 31;11(1):14. doi: 10.1186/s13195-019-0471-6.
7
Associations between quantitative [F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum.定量 [F]flortaucipir tau PET 与阿尔茨海默病谱中萎缩的相关性。
Alzheimers Res Ther. 2019 Jul 4;11(1):60. doi: 10.1186/s13195-019-0510-3.
8
The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study.阿尔茨海默病中神经炎症、β-淀粉样蛋白和 tau 沉积之间的关系:一项纵向 PET 研究。
J Neuroinflammation. 2020 May 6;17(1):151. doi: 10.1186/s12974-020-01820-6.
9
Concordance and Diagnostic Accuracy of [11C]PIB PET and Cerebrospinal Fluid Biomarkers in a Sample of Patients with Mild Cognitive Impairment and Alzheimer's Disease.[11C]PIB正电子发射断层扫描(PET)与脑脊液生物标志物在轻度认知障碍和阿尔茨海默病患者样本中的一致性及诊断准确性
J Alzheimers Dis. 2015;45(4):1077-88. doi: 10.3233/JAD-142952.
10
Evaluation of tau deposition using F-PI-2620 PET in MCI and early AD subjects-a MissionAD tau sub-study.使用 F-PI-2620 PET 评估 MCI 和早期 AD 患者中的 tau 沉积——一项 MissionAD tau 子研究。
Alzheimers Res Ther. 2022 Jul 27;14(1):105. doi: 10.1186/s13195-022-01048-x.

本文引用的文献

1
Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies.睡眠生物标志物预测认知衰退和阿尔茨海默病:纵向研究的系统评价。
J Alzheimers Dis. 2024;97(1):121-143. doi: 10.3233/JAD-230933.
2
Sleep Dysregulation Is Associated with F-FDG PET and Cerebrospinal Fluid Biomarkers in Alzheimer's Disease.睡眠失调与阿尔茨海默病中的氟代脱氧葡萄糖正电子发射断层扫描(F-FDG PET)及脑脊液生物标志物相关。
J Alzheimers Dis Rep. 2023 Aug 10;7(1):845-854. doi: 10.3233/ADR-220111. eCollection 2023.
3
Associations between self-reported sleep quality and cerebrospinal fluid biomarkers in mild cognitive impairment and Alzheimer's disease.
自报睡眠质量与轻度认知障碍和阿尔茨海默病患者脑脊液生物标志物之间的关联。
Rev Neurol (Paris). 2023 Oct;179(8):877-881. doi: 10.1016/j.neurol.2022.12.009. Epub 2023 Mar 11.
4
The evolving role of quantitative actigraphy in clinical sleep medicine.定量活动记录仪在临床睡眠医学中不断演变的作用。
Sleep Med Rev. 2023 Apr;68:101762. doi: 10.1016/j.smrv.2023.101762. Epub 2023 Jan 28.
5
Association of entorhinal cortical tau deposition and hippocampal synaptic density in older individuals with normal cognition and early Alzheimer's disease.在认知正常和早期阿尔茨海默病的老年人中,内嗅皮质 tau 沉积与海马突触密度的关系。
Neurobiol Aging. 2022 Mar;111:44-53. doi: 10.1016/j.neurobiolaging.2021.11.004. Epub 2021 Nov 20.
6
NORMATIVE REFERENCE VALUES FOR ACTIGRAPHY-MEASURED TOTAL NOCTURNAL SLEEP TIME IN THE US POPULATION.美国人群中通过活动记录仪测量的夜间总睡眠时间的标准参考值。
Am J Epidemiol. 2022 Jan 24;191(2):360-362. doi: 10.1093/aje/kwab258.
7
Tau-driven degeneration of sleep- and wake-regulating neurons in Alzheimer's disease.阿尔茨海默病中与睡眠-觉醒调节相关的神经元tau 驱动变性。
Sleep Med Rev. 2021 Dec;60:101541. doi: 10.1016/j.smrv.2021.101541. Epub 2021 Aug 16.
8
Tau and β-Amyloid Burden Predict Actigraphy-Measured and Self-Reported Impairment and Misperception of Human Sleep.tau 和 β-淀粉样蛋白负担预测活动计测量和自我报告的人类睡眠障碍和错觉。
J Neurosci. 2021 Sep 8;41(36):7687-7696. doi: 10.1523/JNEUROSCI.0353-21.2021. Epub 2021 Jul 21.
9
Multicenter Study on Sleep and Circadian Alterations as Objective Markers of Mild Cognitive Impairment and Alzheimer's Disease Reveals Sex Differences.多中心研究睡眠和昼夜节律改变作为轻度认知障碍和阿尔茨海默病的客观标志物揭示了性别差异。
J Alzheimers Dis. 2020;78(4):1707-1719. doi: 10.3233/JAD-200632.
10
Sleep-Wake Cycle in Alzheimer's Disease Is Associated with Tau Pathology and Orexin Dysregulation.阿尔茨海默病的睡眠-觉醒周期与 Tau 病理学和食欲素失调有关。
J Alzheimers Dis. 2020;74(2):501-508. doi: 10.3233/JAD-191124.